These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nonrandom clustering of adverse reactions to iodinated radiographic contrast media used for computed tomography. Winter J J Comput Tomogr; 1982 Sep; 6(2):109-12. PubMed ID: 7172692 [No Abstract] [Full Text] [Related]
3. [Clinical course and CT findings in patients with contrast media-associated seizures]. Onda K; Tekeda N; Tanaka R No To Shinkei; 1987 Apr; 39(4):331-7. PubMed ID: 3593601 [TBL] [Abstract][Full Text] [Related]
4. Comparison of intravenous contrast agents for CT studies in children. Cohen MD; Herman E; Herron D; White SJ; Smith JA Acta Radiol; 1992 Nov; 33(6):592-5. PubMed ID: 1449887 [TBL] [Abstract][Full Text] [Related]
5. Theoretical considerations in the use of contrast media for computed cranial tomography. Davis KR; New PF; Solis OJ; Roberson GH Rev Interam Radiol; 1976 Oct; 1(2):9-12. PubMed ID: 1027072 [TBL] [Abstract][Full Text] [Related]
6. Elevation of serum creatine kinase B-subunit levels by radiographic contrast agents in patients with neurologic disorders. Pfeiffer FE; Homburger HA; Houser OW; Baker HL; Yanagihara T Mayo Clin Proc; 1987 May; 62(5):351-7. PubMed ID: 3573823 [TBL] [Abstract][Full Text] [Related]
7. Contrast-induced encephalopathy and seizures in a patient with chronic renal insufficiency. Muruve DA; Steinman TI Clin Nephrol; 1996 Jun; 45(6):406-9. PubMed ID: 8793235 [TBL] [Abstract][Full Text] [Related]
8. [The rescue of iodine allergy by contrast enhanced CT]. Shen S; Xiao E; Tan L; Wu Y Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):179-80. PubMed ID: 10681839 [TBL] [Abstract][Full Text] [Related]
9. Focal epileptic activity following intravenous contrast material injection in patients with metastatic brain disease. Avrahami E; Weiss-Peretz J; Cohn DF J Neurol Neurosurg Psychiatry; 1987 Feb; 50(2):221-3. PubMed ID: 3106578 [TBL] [Abstract][Full Text] [Related]
10. Nonconvulsive status epilepticus after intravenous contrast medium administration. Lukovits TG; Fadul CE; Pipas JM; Williamson PD Epilepsia; 1996 Nov; 37(11):1117-20. PubMed ID: 8917064 [TBL] [Abstract][Full Text] [Related]
12. Is the safety of contrast agents an issue in body computed tomography? Bernardino ME Invest Radiol; 1993 Nov; 28 Suppl 5():S68-70; discussion S71. PubMed ID: 8282506 [TBL] [Abstract][Full Text] [Related]
13. Inadvertent intrathecal use of ionic contrast agents: treatment with immediate ventriculolumbar lavage. Schwab S; Flügel D; Spranger M; Albert F J Neurol; 1996 Sep; 243(9):671-3. PubMed ID: 8892075 [No Abstract] [Full Text] [Related]
14. A review of the findings on computed cranial tomography following intravenous contrast media. Davis KR; New PF; Solis OJ; Roberson GH Rev Interam Radiol; 1977 Jan; 2(1):15-8. PubMed ID: 866885 [TBL] [Abstract][Full Text] [Related]
15. Prospective randomized trial of iohexol 350 versus meglumine sodium diatrizoate as an oral contrast agent for abdominopelvic computed tomography. Peterson CM; Lin M; Pilgram T; Heiken JP J Comput Assist Tomogr; 2011; 35(2):202-5. PubMed ID: 21412090 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment of patients requiring oral contrast abdominal computed tomography with antiemetics: a randomized controlled trial of efficacy. Garra G; Singer AJ; Bamber D; Chohan J; Troxell R; Thode HC Ann Emerg Med; 2009 Apr; 53(4):528-33. PubMed ID: 18640743 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of contrast agents in computed tomography scanning of the brain. Norman D; Enzmann DR; Newton TH J Comput Assist Tomogr; 1978 Jul; 2(3):319-21. PubMed ID: 263498 [TBL] [Abstract][Full Text] [Related]